Structure of SARS-CoV-2 spike with antibody Fabs 2A10 and 1H2 (Local refinement of the RBD and Fabs 1H2 and 2A10)

alpha-L-fucose; 6-deoxy-alpha-L-galactopyranose; L-fucose; fucose

N-acetyl-beta-D-glucosamine; 2-acetamido-2-deoxy-beta-D-glucose; 2-acetamido-2-deoxy-D-glucose; 2-acetamido-2-deoxy-glucose; N-ACETYL-D-GLUCOSAMINE

Potent Omicron-neutralizing antibodies isolated from a patient vaccinated 6 months before Omicron emergence.

Structure of SARS-CoV-2 D614G spike in complex with antibody Fabs 1H2 and 2A10

Antibody Fab 1H2 heavy chain, Antibody Fab 1H2 light chain, Antibody Fab 2A10 heavy chain, Antibody Fab 2A10 light chain

Severe acute respiratory syndrome coronavirus 2

National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)

VIRAL PROTEIN, glycoprotein, immune system, antibody, SARS-CoV-2, COVID, VIRAL PROTEIN-Immune System complex, coronavirus